Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease

Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Postgraduate medical journal 2009-03, Vol.85 (1001), p.141-147
Hauptverfasser: Black, P N, McDonald, C F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 147
container_issue 1001
container_start_page 141
container_title Postgraduate medical journal
container_volume 85
creator Black, P N
McDonald, C F
description Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.
doi_str_mv 10.1136/pgmj.2008.072439
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67110301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4026196091</sourcerecordid><originalsourceid>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</originalsourceid><addsrcrecordid>eNqFkE1r3DAQhkVpaTbb3nsKgtJcgreSJUv2MSzNB4RtD22uQpZHiTe2tJHkkPz7avGSQC89Dcw8M7zzIPSFkhWlTHzf3Y3bVUlIvSKy5Kx5hxaUi6YgshLv0YIQVhYVl-wIHce4JYQyyelHdEQbVlHB6QKpa5cgPIFLvXcRJ48DdJMBnO4B2wCPEzjzgr3F8KwNhFbPYG6Y--Bdb7BvYwqTSf0T4N00jN7p8IK7PoKO8Al9sHqI8PlQl-jPxY_f66vi5ufl9fr8pmh52aSClwKkAFG3TJBacq3rrq6oZLyxUuZquZWUQyO7CnKPQ36mllVjbNkZC2yJTue7u-Bz5pjU2EcDw6Ad-CkqISklLAtYoq__gFs_BZezKSrrLIVTITJFZsoEH2MAq3ahH_NfihK1V6_26tVevZrV55WTw-GpHaF7Wzi4zsC3A6Cj0YMN2pk-vnIlZbzijGeumLk-Jnh-nevwkL9gslKb27W63fwSZHNVqn3Ws5lvc6L_xvwL6cepXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781644166</pqid></control><display><type>article</type><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><source>MEDLINE</source><source>BMJ Journals - NESLi2</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Black, P N ; McDonald, C F</creator><creatorcontrib>Black, P N ; McDonald, C F</creatorcontrib><description>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</description><identifier>ISSN: 0032-5473</identifier><identifier>EISSN: 1469-0756</identifier><identifier>DOI: 10.1136/pgmj.2008.072439</identifier><identifier>PMID: 19351641</identifier><language>eng</language><publisher>London: The Fellowship of Postgraduate Medicine</publisher><subject>Acute Disease ; Administration, Inhalation ; Adrenal Cortex Hormones - therapeutic use ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Bacteria ; Biological and medical sciences ; Bronchodilator Agents - therapeutic use ; chronic airways disease ; Chronic obstructive pulmonary disease ; emphysema ; Expectorants - therapeutic use ; General aspects ; Health care expenditures ; Hospitalization ; Hospitals ; Humans ; long-acting inhaled β agonists ; Medical sciences ; Patient admissions ; Phosphodiesterase Inhibitors - therapeutic use ; Pneumonia ; Pulmonary Disease, Chronic Obstructive - drug therapy ; respiratory infections ; Scopolamine Derivatives - therapeutic use ; Steroids ; thoracic medicine ; Tiotropium Bromide ; Vaccination - methods</subject><ispartof>Postgraduate medical journal, 2009-03, Vol.85 (1001), p.141-147</ispartof><rights>2009 The Fellowship of Postgraduate Medicine</rights><rights>2009 INIST-CNRS</rights><rights>Copyright: 2009 2009 The Fellowship of Postgraduate Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</citedby><cites>FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pmj.bmj.com/content/85/1001/141.full.pdf$$EPDF$$P50$$Gbmj$$H</linktopdf><linktohtml>$$Uhttps://pmj.bmj.com/content/85/1001/141.full$$EHTML$$P50$$Gbmj$$H</linktohtml><link.rule.ids>114,115,314,776,780,3182,23551,27903,27904,77346,77377</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21345434$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19351641$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Black, P N</creatorcontrib><creatorcontrib>McDonald, C F</creatorcontrib><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><title>Postgraduate medical journal</title><addtitle>Postgrad Med J</addtitle><description>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</description><subject>Acute Disease</subject><subject>Administration, Inhalation</subject><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Biological and medical sciences</subject><subject>Bronchodilator Agents - therapeutic use</subject><subject>chronic airways disease</subject><subject>Chronic obstructive pulmonary disease</subject><subject>emphysema</subject><subject>Expectorants - therapeutic use</subject><subject>General aspects</subject><subject>Health care expenditures</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>long-acting inhaled β agonists</subject><subject>Medical sciences</subject><subject>Patient admissions</subject><subject>Phosphodiesterase Inhibitors - therapeutic use</subject><subject>Pneumonia</subject><subject>Pulmonary Disease, Chronic Obstructive - drug therapy</subject><subject>respiratory infections</subject><subject>Scopolamine Derivatives - therapeutic use</subject><subject>Steroids</subject><subject>thoracic medicine</subject><subject>Tiotropium Bromide</subject><subject>Vaccination - methods</subject><issn>0032-5473</issn><issn>1469-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkE1r3DAQhkVpaTbb3nsKgtJcgreSJUv2MSzNB4RtD22uQpZHiTe2tJHkkPz7avGSQC89Dcw8M7zzIPSFkhWlTHzf3Y3bVUlIvSKy5Kx5hxaUi6YgshLv0YIQVhYVl-wIHce4JYQyyelHdEQbVlHB6QKpa5cgPIFLvXcRJ48DdJMBnO4B2wCPEzjzgr3F8KwNhFbPYG6Y--Bdb7BvYwqTSf0T4N00jN7p8IK7PoKO8Al9sHqI8PlQl-jPxY_f66vi5ufl9fr8pmh52aSClwKkAFG3TJBacq3rrq6oZLyxUuZquZWUQyO7CnKPQ36mllVjbNkZC2yJTue7u-Bz5pjU2EcDw6Ad-CkqISklLAtYoq__gFs_BZezKSrrLIVTITJFZsoEH2MAq3ahH_NfihK1V6_26tVevZrV55WTw-GpHaF7Wzi4zsC3A6Cj0YMN2pk-vnIlZbzijGeumLk-Jnh-nevwkL9gslKb27W63fwSZHNVqn3Ws5lvc6L_xvwL6cepXg</recordid><startdate>20090301</startdate><enddate>20090301</enddate><creator>Black, P N</creator><creator>McDonald, C F</creator><general>The Fellowship of Postgraduate Medicine</general><general>BMJ Publishing Group</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20090301</creationdate><title>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</title><author>Black, P N ; McDonald, C F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b429t-426e76e68b360874aa8d8517349f77173f4f714e97d5e49f4e0018759cf2dcfe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acute Disease</topic><topic>Administration, Inhalation</topic><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Biological and medical sciences</topic><topic>Bronchodilator Agents - therapeutic use</topic><topic>chronic airways disease</topic><topic>Chronic obstructive pulmonary disease</topic><topic>emphysema</topic><topic>Expectorants - therapeutic use</topic><topic>General aspects</topic><topic>Health care expenditures</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>long-acting inhaled β agonists</topic><topic>Medical sciences</topic><topic>Patient admissions</topic><topic>Phosphodiesterase Inhibitors - therapeutic use</topic><topic>Pneumonia</topic><topic>Pulmonary Disease, Chronic Obstructive - drug therapy</topic><topic>respiratory infections</topic><topic>Scopolamine Derivatives - therapeutic use</topic><topic>Steroids</topic><topic>thoracic medicine</topic><topic>Tiotropium Bromide</topic><topic>Vaccination - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Black, P N</creatorcontrib><creatorcontrib>McDonald, C F</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Postgraduate medical journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Black, P N</au><au>McDonald, C F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease</atitle><jtitle>Postgraduate medical journal</jtitle><addtitle>Postgrad Med J</addtitle><date>2009-03-01</date><risdate>2009</risdate><volume>85</volume><issue>1001</issue><spage>141</spage><epage>147</epage><pages>141-147</pages><issn>0032-5473</issn><eissn>1469-0756</eissn><abstract>Frequent exacerbations of chronic obstructive pulmonary disease (COPD) are associated with impaired quality of life, and hospital admissions for exacerbations account for a large proportion of the expenditure of COPD. An important objective when treating COPD is to reduce the frequency of exacerbations. Studies published in the last few years have increased our knowledge on how to prevent exacerbations, but a number of questions remain unanswered. Tiotropium, inhaled steroids and long-acting inhaled β agonists reduce the frequency of exacerbations, but further studies are necessary to determine if combining tiotropium with the other inhaled medicines is more effective than using them separately. There is evidence that mucolytics and prophylactic antibiotics reduce exacerbations, but there is uncertainty how these treatments should be used. Both influenza and pneumococcal vaccination are recommended in guidelines, although evidence for the latter remains controversial. Other interventions including oral bacterial extracts and self-management programmes warrant further study.</abstract><cop>London</cop><pub>The Fellowship of Postgraduate Medicine</pub><pmid>19351641</pmid><doi>10.1136/pgmj.2008.072439</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0032-5473
ispartof Postgraduate medical journal, 2009-03, Vol.85 (1001), p.141-147
issn 0032-5473
1469-0756
language eng
recordid cdi_proquest_miscellaneous_67110301
source MEDLINE; BMJ Journals - NESLi2; Oxford University Press Journals All Titles (1996-Current)
subjects Acute Disease
Administration, Inhalation
Adrenal Cortex Hormones - therapeutic use
Anti-Bacterial Agents - therapeutic use
Antibiotics
Bacteria
Biological and medical sciences
Bronchodilator Agents - therapeutic use
chronic airways disease
Chronic obstructive pulmonary disease
emphysema
Expectorants - therapeutic use
General aspects
Health care expenditures
Hospitalization
Hospitals
Humans
long-acting inhaled β agonists
Medical sciences
Patient admissions
Phosphodiesterase Inhibitors - therapeutic use
Pneumonia
Pulmonary Disease, Chronic Obstructive - drug therapy
respiratory infections
Scopolamine Derivatives - therapeutic use
Steroids
thoracic medicine
Tiotropium Bromide
Vaccination - methods
title Interventions to reduce the frequency of exacerbations of chronic obstructive pulmonary disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T14%3A53%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interventions%20to%20reduce%20the%20frequency%20of%20exacerbations%20of%20chronic%20obstructive%20pulmonary%20disease&rft.jtitle=Postgraduate%20medical%20journal&rft.au=Black,%20P%20N&rft.date=2009-03-01&rft.volume=85&rft.issue=1001&rft.spage=141&rft.epage=147&rft.pages=141-147&rft.issn=0032-5473&rft.eissn=1469-0756&rft_id=info:doi/10.1136/pgmj.2008.072439&rft_dat=%3Cproquest_cross%3E4026196091%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1781644166&rft_id=info:pmid/19351641&rfr_iscdi=true